In a major policy shift, the U.S. Food and Drug Administration is reconsidering restrictions on several controversial peptides, including trending compounds like BPC 157 and Melanotan II. The move comes as demand for Melanotan II in Santa Barbara, CA Eternity Health Partners Nasal tanning sprays linked to skin cancer, trading standards officers warn Consumer affairs The Guardian Melanotan II: Tanning injections, nasal sprays harmful to health What Peptides Are Legal in the U.S.? Understanding FDA Approval, Compounding, and the Legal Gray Areas Holt Law